Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients

Jung U. Shin, Sang Wook Kang, Jong Ju Jeong, Kee Hyun Nam, Woong Youn Chung, JuHee Lee

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Epidermal growth factor (EGF) decreases inflammatory cell infiltration and TGF-β expression during wound healing. Several clinical studies show that recovery of various ulcer wounds, such as diabetic and radiation ulcer, is promoted by EGF. Objective: To evaluate effects of recombinant human epidermal growth factor (rhEGF) on cutaneous scar quality after thyroidectomy. Method: Scar quality was evaluated by Vancouver scar scale (VSS) in two groups of female thyroidectomy patients (control, n=11; rhEGF-treated, n=10). Scar erythema, pigmentation, elasticity and hydration were measured by mexameter, cutometer and corneometer. Results: Scar pliability (at 4 weeks) and thickness (2 weeks) after surgery were significantly lower in the rhEGF group than control. Total VSS score was significantly lower in the rhEGF group after 4 weeks. However, erythema, pigmentation, elasticity and hydration of the scar were not significantly different between groups. Conclusion: The early use of rhEGF in surgical wound healing may improve cutaneous scar quality.

Original languageEnglish
Pages (from-to)159-164
Number of pages6
JournalJournal of Dermatological Treatment
Volume26
Issue number2
DOIs
Publication statusPublished - 2015 Apr 1

Fingerprint

Thyroidectomy
Epidermal Growth Factor
Cicatrix
Skin
Elasticity
Pigmentation
Erythema
Wound Healing
Ulcer
Pliability
Radiation
Control Groups
Wounds and Injuries

All Science Journal Classification (ASJC) codes

  • Dermatology

Cite this

Shin, Jung U. ; Kang, Sang Wook ; Jeong, Jong Ju ; Nam, Kee Hyun ; Chung, Woong Youn ; Lee, JuHee. / Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients. In: Journal of Dermatological Treatment. 2015 ; Vol. 26, No. 2. pp. 159-164.
@article{97424a70f47b49fab117c85e9b2bf31c,
title = "Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients",
abstract = "Epidermal growth factor (EGF) decreases inflammatory cell infiltration and TGF-β expression during wound healing. Several clinical studies show that recovery of various ulcer wounds, such as diabetic and radiation ulcer, is promoted by EGF. Objective: To evaluate effects of recombinant human epidermal growth factor (rhEGF) on cutaneous scar quality after thyroidectomy. Method: Scar quality was evaluated by Vancouver scar scale (VSS) in two groups of female thyroidectomy patients (control, n=11; rhEGF-treated, n=10). Scar erythema, pigmentation, elasticity and hydration were measured by mexameter, cutometer and corneometer. Results: Scar pliability (at 4 weeks) and thickness (2 weeks) after surgery were significantly lower in the rhEGF group than control. Total VSS score was significantly lower in the rhEGF group after 4 weeks. However, erythema, pigmentation, elasticity and hydration of the scar were not significantly different between groups. Conclusion: The early use of rhEGF in surgical wound healing may improve cutaneous scar quality.",
author = "Shin, {Jung U.} and Kang, {Sang Wook} and Jeong, {Jong Ju} and Nam, {Kee Hyun} and Chung, {Woong Youn} and JuHee Lee",
year = "2015",
month = "4",
day = "1",
doi = "10.3109/09546634.2014.906034",
language = "English",
volume = "26",
pages = "159--164",
journal = "Journal of Dermatological Treatment",
issn = "0954-6634",
publisher = "Informa Healthcare",
number = "2",

}

Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients. / Shin, Jung U.; Kang, Sang Wook; Jeong, Jong Ju; Nam, Kee Hyun; Chung, Woong Youn; Lee, JuHee.

In: Journal of Dermatological Treatment, Vol. 26, No. 2, 01.04.2015, p. 159-164.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effect of recombinant human epidermal growth factor on cutaneous scar quality in thyroidectomy patients

AU - Shin, Jung U.

AU - Kang, Sang Wook

AU - Jeong, Jong Ju

AU - Nam, Kee Hyun

AU - Chung, Woong Youn

AU - Lee, JuHee

PY - 2015/4/1

Y1 - 2015/4/1

N2 - Epidermal growth factor (EGF) decreases inflammatory cell infiltration and TGF-β expression during wound healing. Several clinical studies show that recovery of various ulcer wounds, such as diabetic and radiation ulcer, is promoted by EGF. Objective: To evaluate effects of recombinant human epidermal growth factor (rhEGF) on cutaneous scar quality after thyroidectomy. Method: Scar quality was evaluated by Vancouver scar scale (VSS) in two groups of female thyroidectomy patients (control, n=11; rhEGF-treated, n=10). Scar erythema, pigmentation, elasticity and hydration were measured by mexameter, cutometer and corneometer. Results: Scar pliability (at 4 weeks) and thickness (2 weeks) after surgery were significantly lower in the rhEGF group than control. Total VSS score was significantly lower in the rhEGF group after 4 weeks. However, erythema, pigmentation, elasticity and hydration of the scar were not significantly different between groups. Conclusion: The early use of rhEGF in surgical wound healing may improve cutaneous scar quality.

AB - Epidermal growth factor (EGF) decreases inflammatory cell infiltration and TGF-β expression during wound healing. Several clinical studies show that recovery of various ulcer wounds, such as diabetic and radiation ulcer, is promoted by EGF. Objective: To evaluate effects of recombinant human epidermal growth factor (rhEGF) on cutaneous scar quality after thyroidectomy. Method: Scar quality was evaluated by Vancouver scar scale (VSS) in two groups of female thyroidectomy patients (control, n=11; rhEGF-treated, n=10). Scar erythema, pigmentation, elasticity and hydration were measured by mexameter, cutometer and corneometer. Results: Scar pliability (at 4 weeks) and thickness (2 weeks) after surgery were significantly lower in the rhEGF group than control. Total VSS score was significantly lower in the rhEGF group after 4 weeks. However, erythema, pigmentation, elasticity and hydration of the scar were not significantly different between groups. Conclusion: The early use of rhEGF in surgical wound healing may improve cutaneous scar quality.

UR - http://www.scopus.com/inward/record.url?scp=84930792172&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84930792172&partnerID=8YFLogxK

U2 - 10.3109/09546634.2014.906034

DO - 10.3109/09546634.2014.906034

M3 - Article

VL - 26

SP - 159

EP - 164

JO - Journal of Dermatological Treatment

JF - Journal of Dermatological Treatment

SN - 0954-6634

IS - 2

ER -